Dissolution kinetics evaluation of controlled-release tablets containing propranolol hydrochloride
Author
dc.contributor.author
Velasco-De-Paola, M. V.R.
Author
dc.contributor.author
Santoro, M. I.R.M.
Author
dc.contributor.author
Gai, M. N.
Admission date
dc.date.accessioned
2018-12-20T15:04:07Z
Available date
dc.date.available
2018-12-20T15:04:07Z
Publication date
dc.date.issued
1999
Cita de ítem
dc.identifier.citation
Drug Development and Industrial Pharmacy, Volumen 25, Issue 4, 2018, Pages 535-541
Identifier
dc.identifier.issn
03639045
Identifier
dc.identifier.other
10.1081/DDC-100102205
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/157453
Abstract
dc.description.abstract
In the present research, controlled-release propranolol hydrochloride tablets were prepared for twice-daily administration, allowing more uniform plasmatic levels of the drug. Pharmaceutical formulations were prepared with hydrophobic Eudragit® RSPO. The physical properties of the tablets were determined. Dissolution tests were performed in capsules containing the raw material using the following dissolution media: (A) distilled water, (B) simulated gastric juice without enzymes, and (C) simulated enteric juice without enzymes. A dissolution test was also performed for simulated samples (tablets) using distilled water as the dissolution medium.